價格 | 詢價 | ||
包裝 | 100ul | 500ul | 1000ul |
最小起訂量 | 100ul |
發(fā)貨地 | 北京 |
更新日期 | 2024-12-16 |
中文名稱:IFNγ抗體 | 英文名稱:Anti IFNγ |
品牌: 百普賽斯 | 產(chǎn)地: 北京 |
保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
產(chǎn)品類別: 抗體 | |
抗體名: IFNγ | 靶點: IFNγ |
宿主: HEK293 | 適應(yīng)物種: 人/鼠/猴/兔等 |
克隆性: 單克隆 |
抗體來源(Source)
Biotinylated Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
克隆號(Clone)
13E6H4
亞型(Isotype)
Human IgG1/kappa
偶聯(lián)(Conjugate)
Biotin
抗體類型(Antibody Type)
Recombinant Monoclonal
種屬反應(yīng)性(Reactivity)
Human
免疫原(Immunogen)
Recombinant Human IFNγ is expressed from human HEK293 cells.
特異性(Specificity)
This product is a specific antibody specifically reacts with IFN-γ, Human. No cross-reactivity is detected with other human cytokines, including IL-2, IL-4, IL-6, IL-10, GM-CSF and TNF-alpha.
應(yīng)用(Application)
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
純化(Purification)
Protein A purified/ Protein G purified
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression.
成立日期 | 2010-07-22 (15年) | 注冊資本 | 8000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1120.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2025-01-24 | |
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2025-01-17 | |
¥2640 |
VIP4年
|
上海博爾森生物科技有限公司
|
2025-01-17 |